Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Comparable Progression-Free and Overall Survival Following Transplantation of Single Cord Blood with HLA-Matched Related Donor in Adults with Non-Remission Myeloid Malignancies

Hisashi Yamamoto, MD, Naoyuki Uchida, MD PhD, Mitsuhiro Yuasa, MD, Kosei Kageyama, MD, Aya Nishida, MD, Kazuya Ishiwata, MD, Shinsuke Takagi, MD PhD, Yuki Asano-Mori, MD PhD, Go Yamamoto, MD PhD, Koji Izutsu, MD PhD, Atsushi Wake, MD PhD, Akiko Yoneyama, MD PhD, Shigeyoshi Makino, MD PhD, Shuichi Taniguchi, MD PhD

Blood (2016) 128 (22): 2303.

https://doi.org/10.1182/blood.V128.22.2303.2303

Published: 2016

Journal Articles

High Disease-Free and Overall Survival Rate Following Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia Even in Non-Remission Status

Aya Nishida, MD, Mitsuhiro Yuasa, MD, Kosei Kageyama, MD, Kazuya Ishiwata, MD, Shinsuke Takagi, MD PhD, Hisashi Yamamoto, MD, Yuki Asano-Mori, MD PhD, Go Yamamoto, MD PhD, Naoyuki Uchida, MD PhD, Koji Izutsu, MD PhD, Atsushi Wake, MD, Akiko Yoneyama, MD PhD, Shigeyoshi Makino, MD PhD, Shuichi Taniguchi, MD PhD

Blood (2016) 128 (22): 2283.

https://doi.org/10.1182/blood.V128.22.2283.2283

Published: 2016

Journal Articles

Possible Therapeutic Potential of Recombinant Human Soluble Thrombomoduline Alpha for the Treatment of SOS/VOD: A Retrospective Study in Toranomon Hospital

Shinsuke Takagi, MD PhD, Mitsuhiro Yuasa, MD, Naoyuki Uchida, MD PhD, Kyosuke Yamaguchi, MD, Kosei Kageyama, MD, Daisuke Kaji, MD, Yuki Taya, MD PhD, Aya Nishida, MD, Kazuya Ishiwata, MD, Hisashi Yamamoto, MD, Go Yamamoto, MD PhD, Yuki Asano-Mori, MD PhD, Atsushi Wake, MD PhD, Shigeyoshi Makino, MD PhD, Akiko Yoneyama, MD PhD, Koji Izutsu, MD PhD, Shuichi Taniguchi, MD PhD

Blood (2016) 128 (22): 5747.

https://doi.org/10.1182/blood.V128.22.5747.5747

Published: 2016

Journal Articles

Umbilical Cord Blood Is the Most Significant Risk Factor for the Development of Bloodstream Infection after Allogeneic Hematopoietic Cell Transplantation

Shinsuke Takagi, MD PhD, Hideki Araoka, MD, Naoyuki Uchida, MDPhD, Masahiro Abe, MD, Mitsuhiro Yuasa, MD, Kosei Kageyama, MD, Daisuke Kaji, MD, Aya Nishida, MD, Muneyoshi Kimura, MD, Kazuya Ishiwata, MD, Hisashi Yamamoto, MD, Go Yamamoto, MD PhD, Yuki Asano-Mori, MD PhD, Koji Izutsu, MD PhD, Atsushi Wake, MD PhD, Akiko Yoneyama, MD PhD, Shuichi Taniguchi, MD PhD

Blood (2015) 126 (23): 1905.

https://doi.org/10.1182/blood.V126.23.1905.1905

Published: 2015

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia Transformed from Ph-Negative Myeloproliferative Neoplasm: A Study from the Adult AML Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Shinsuke Takagi, MD PhD, Kazuhiro Masuoka, Naoyuki Uchida, MD PhD, Mineo Kurokawa, MD PhD, Hirohisa Nakamae, Mitsuru Tsudo, Koji Iwato, Tatsuo Ichinohe, Yoshiko Atsuta, Akiyoshi Takami

Blood (2014) 124 (21): 2547.

https://doi.org/10.1182/blood.V124.21.2547.2547

Published: 2014

Journal Articles

Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases

Hiroki Mizumaki, MD, Shinsuke Takagi, MD PhD, Naoyuki Uchida, MD PhD, Sachie Wada, MD, Kosei Kageyama, MD, Daisuke Kaji, MD, Aya Nishida, MD, Kazuya Ishiwata, MD, Masanori Tsuji, MD, Hisashi Yamamoto, MD, Go Yamamoto, MD PhD, Yuki Asano-Mori, MD PhD, Shigeyoshi Makino, MD PhD, Akiko Yoneyama, MD PhD, Atsushi Wake, MD PhD, Koji Izutsu, Shuichi Taniguchi, MD PhD

Blood (2014) 124 (21): 5931.

https://doi.org/10.1182/blood.V124.21.5931.5931

Published: 2014

Journal Articles

Clinical Comparison of Incidences, Risk Factors and Outocmes of Chronic Graft-Versus-Host Desease in Unrelated Cord Blood Transplantation and Unrelated Bone Marrow Transplantation

Yuki Asano-Mori, MD PhD, Atsushi Wake, MD PhD, Kosei Kageyama, MD, Daisuke Kaji, MD, Kazuya Ishiwata, MD, Shinsuke Takagi, MD PhD, Hisashi Yamamoto, MD, Go Yamamoto, MD PhD, Naoyuki Uchida, MD PhD, Koji Izutsu, Akiko Yoneyama, MD PhD, Shigeyoshi Makino, MD PhD, Shuichi Taniguchi, MD PhD

Blood (2014) 124 (21): 1172.

https://doi.org/10.1182/blood.V124.21.1172.1172

Published: 2014

Journal Articles

Early Central Nervous System Complications after Allogeneic Stem Transplantation: A Single-Center Analysis of 723 Patients Including 456 Cord Blood Recipients

Kosei Kageyama, MD, Hisashi Yamamoto, MD, Mitsuhiro Yuasa, MD, Daisuke Kaji, MD, Sachie Wada, MD, Aya Nishida, MD, Kazuya Ishiwata, MD, Shinsuke Takagi, MD PhD, Masanori Tsuji, MD, Go Yamamoto, MD PhD, Yuki Asano-Mori, MD PhD, Naoyuki Uchida, MD PhD, Koji Izutsu, Atsushi Wake, MD PhD, Akiko Yoneyama, MD PhD, Shigeyoshi Makino, MD PhD, Shuichi Taniguchi, MD PhD

Blood (2014) 124 (21): 2468.

https://doi.org/10.1182/blood.V124.21.2468.2468

Published: 2014

Journal Articles

Second Cord Blood Transplantation for Relapsed Myeloid Malignancies Following Allogeneic Transplantation – a Single Institute Analysis for 85 Recipients

Mitsuhiro Yuasa, MD, Hisashi Yamamoto, MD, Kosei Kageyama, MD, Daisuke Kaji, MD, Sachie Wada, MD, Aya Nishida, MD, Shinsuke Takagi, MD PhD, Masanori Tsuji, MD, Go Yamamoto, MD PhD, Yuki Asano-Mori, MD PhD, Naoyuki Uchida, MD PhD, Koji Izutsu, Atsushi Wake, MD PhD, Akiko Yoneyama, MD PhD, Shigeyoshi Makino, MD PhD, Shuichi Taniguchi, MD PhD

Blood (2014) 124 (21): 2565.

https://doi.org/10.1182/blood.V124.21.2565.2565

Published: 2014

Journal Articles

A Novel Reduced-Toxicity Myeloablative Conditioningusing Full-Dose Busulfan and Melphalan For Cord Blood Transplantation Provides Durable Engraftment and Remission Without Increasing Non-Relapse Mortality In Advanced Myeloid Malignancies

Hisashi Yamamoto, MD, Naoyuki Uchida, MD, PhD, Kousei Kageyama, MD, Daisuke Kaji, MD, Sachie Wada, MD, Aya Nishida, MD, Hikari Ota, MD, Kazuya Ishiwata, MD, Masanori Tsuji, MD, Shinsuke Takagi, MD, Go Yamamoto, MD, PhD, Yuki Asano-Mori, MD, PhD, Koji Izutsu, MD, PhD, Atsushi Wake, MD, PhD, Shuichi Taniguchi, MD, PhD

Blood (2013) 122 (21): 2042.

https://doi.org/10.1182/blood.V122.21.2042.2042

Published: 2013

Journal Articles

Infliximab Versus Rabbit Anti-Thymocyte Globulin As a Salvage Treatment For Steroid-Refractory Acute Graft-Versus-Host Disease After Reduced-Intensity Cord Blood Transplantation In Adults

Kazuya Ishiwata, MD, Hisashi Yamamoto, MD, Kousei Kageyama, MD, Daisuke Kaji, MD, Sachie Wada, MD, Aya Nishida, MD, Hikari Ota, MD, Shinsuke Takagi, MD, Masanori Tsuji, MD, Go Yamamoto, MD, PhD, Yuki Asano-Mori, MD, PhD, Naoyuki Uchida, MD, PhD, Koji Izutsu, MD, PhD, Atsushi Wake, MD, PhD, Akiko Yoneyama, MD, PhD, Shigeyoshi Makino, MD, PhD, Shuichi Taniguchi, MD, PhD

Blood (2013) 122 (21): 4592.

https://doi.org/10.1182/blood.V122.21.4592.4592

Published: 2013

Journal Articles

Membrane-Bound Human Stem Cell Factor Promotes Differentiation of Human Granulocytes and Mast Cells In Vivo,

Shinsuke Takagi, MD, Yoriko Saito, MD, Atsushi Hijikata, PhD, Satoshi Tanaka, Takashi Watanabe, PhD, Haruhiko Koseki, MD, PhD, Osamu Ohara, PhD, Takashi Saito, PhD, Shuichi Taniguchi, MD, PhD, Leonard Shultz, PhD, Fumihiko Ishikawa, MD, PhD

Blood (2011) 118 (21): 3419.

https://doi.org/10.1182/blood.V118.21.3419.3419

Published: 2011

Journal Articles

Clostridium Difficile Infections After Allogenic Hematopoietic Stem Cell Transplantation: Comparison of Cord Blood to Other Grafts

Kohei Hosokawa, MD, Masanori Tsuji, MD, Hideki Araoka, MD, Kazuya Ishiwata, MD, Shinsuke Takagi, MD, Hisashi Yamamoto, MD, Yuki Asano-Mori, MD, PhD, Naofumi Matsuno, MD, PhD, Naoyuki Uchida, MD, PhD, Kazuhiro Masuoka, MD, Atsushi Wake, MD, PhD, Shigeyoshi Makino, MD, PhD, Akiko Yoneyama, MD, PhD, Akiyoshi Takami, MD PhD, Shinji Nakao, MD, PhD, Shuichi Taniguchi, MD, PhD

Blood (2011) 118 (21): 4573.

https://doi.org/10.1182/blood.V118.21.4573.4573

Published: 2011

Journal Articles

Cell Cycle Entry Potentiates Elimination of Chemotherapy-Resistant Human AML Stem Cells.

Yoriko Saito, MD, Naoyuki Uchida, MD, PhD, Satoshi Tanaka, Mariko Tomizawa-Murasawa, Nahoko Suzuki, Shinsuke Takagi, MD, Yuho Najima, MD, Yuki Aoki, MD, Akiko Sone, Atsushi Wake, MD, Shuichi Taniguchi, MD, PhD, Leonard D. Shultz, PhD, Fumihiko Ishikawa, MD, PhD

Blood (2009) 114 (22): 1422.

https://doi.org/10.1182/blood.V114.22.1422.1422

Published: 2009

Journal Articles

Pre-Transplant Conditioning Using Intravenous Busulfan Is a Feasible and Effective Option in Reduced-Intensity Cord Blood Transplantation.

Naoyuki Uchida, MD, Hisashi Yamamoto, MD, Naofumi Matsuno, MD, Kazuya Ishiwata, MD, Masanori Tsuji, MD, Shinsuke Takagi, MD, Hideki Araoka, MD, Daisuke Kato, MD, Mayumi Yoshimi, MD, Sachiko Seo, MD, Kazuhiro Masuoka, MD, Atsushi Wake, MD, Madoka Narita, Kimiko Sagawa, Akiko Yoneyama, MD, Shigeyoshi Makino, MD, Shuichi Taniguchi, MD, PhD

Blood (2008) 112 (11): 3273.

https://doi.org/10.1182/blood.V112.11.3273.3273

Published: 2008

Journal Articles

HHV6-Associated Limbic Encephalitis after Reduced-Intensity Umbilical Cord Blood Transplantation.

Kazuya Ishiwata, MD, Hisashi Yamamoto, MD, Shinsuke Takagi, MD, Masanori Tsuji, MD, Daisuke Kato, MD, Hideki Araoka, MD, Mayumi Yoshimi, MD, Madoka Narita, Kimiko Sagawa, Naofumi Matsuno, MD, Naoyuki Uchida, MD, Kazuhiro Masuoka, MD, Atsushi Wake, MD, Akiko Yoneyama, MD, Shigeyoshi Makino, MD, Shuichi Taniguchi, MD, PhD

Blood (2008) 112 (11): 2208.

https://doi.org/10.1182/blood.V112.11.2208.2208

Published: 2008

Journal Articles

Voriconazole Is Safe and Effective as a Prophylactic Regimen of Invasive Fungal Infections for High Risk Patients after Reduced-Intensity Umbilical Cord Blood Transplantation

Shinsuke Takagi, MD, Kazuya Ishiwata, MD, Masanori Tsuji, MD, Hisashi Yamamoto, MD, Daisuke Kato, MD, Sachiko Seo, MD, Naofumi Matsuno, MD, Naoyuki Uchida, MD, Kazuhiro Masuoka, MD, Atsushi Wake, MD, Shigeyoshi Makino, MD, Akiko Yoneyama, MD, Shuichi Taniguchi, MD

Blood (2008) 112 (11): 4355.

https://doi.org/10.1182/blood.V112.11.4355.4355

Published: 2008

Journal Articles

Comparison of Outcomes of Bone Marrow and Umbilical Cord Blood Transplants from Unrelated Donors in Adult Patients with Acute Myeloid Leukemia/Myelodysplastic Syndrome.

Kazuhiro Masuoka, MD, Shigesaburo Miyakoshi, MD, Kazuya Ishiwata, MD, Masanori Tsuji, MD, Shinsuke Takagi, MD, Hisashi Yamamoto, MD, Daisuke Kato, MD, Keiko Matsuhashi, MD, Sachiko Seo, MD, Naofumi Matsuno, MD, Naoyuki Uchida, MD, Atsushi Wake, MD, Akiko Yoneyama, MD, Shuichi Taniguchi, MD

Blood (2007) 110 (11): 2010.

https://doi.org/10.1182/blood.V110.11.2010.2010

Published: 2007

Journal Articles

Comparative Single-Institute Analysis of Cord Blood Transplantation from Unrelated Donors with Unrelated Bone Marrow or Related Peripheral Blood Stem-Cell Transplants in Elderly Patients with Hematologic Diseases after Reduced Intensity-Conditioning Regimen.

Naoyuki Uchida, MD, Atsushi Wake, MD, Kazuhiro Masuoka, MD, Kazuya Ishiwata, MD, Masanori Tsuji, MD, Hisashi Yamamoto, MD, Shinsuke Takagi, MD, Daisuke Kato, MD, Sachiko Seo, MD, Naofumi Matsuno, MD, Shigesaburo Miyakoshi, MD, Akiko Yoneyama, MD, Shuichi Taniguchi, MD

Blood (2007) 110 (11): 2011.

https://doi.org/10.1182/blood.V110.11.2011.2011

Published: 2007

Journal Articles

Bloodstream Infection after Reduced-Intensity Umbilical Cord Blood Transplantation Versus Other Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation.

Shinsuke Takagi, MD, Kazuya Ishiwata, MD, Masanori Tsuji, MD, Hisashi Yamamoto, MD, Daisuke Kato, MD, Yoshiko Matsuhashi, MD, Eiji Kusumi, MD, Sachiko Seo, MD, Naofumi Matsuno, MD, Tomoko Matsumura, MD, Naoyuki Uchida, MD, Kazuhiro Masuoka, MD, Atsushi Wake, MD, Shigesaburo Miyakoshi, MD, Akiko Yoneyama, MD, Michio Matsuzaki, MD, Shuichi Taniguchi, MD

Blood (2007) 110 (11): 4981.

https://doi.org/10.1182/blood.V110.11.4981.4981

Published: 2007

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Comparable Progression-Free and Overall Survival Following Transplantation of Single Cord Blood with HLA-Matched Related Donor in Adults with Non-Remission Myeloid Malignancies

High Disease-Free and Overall Survival Rate Following Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia Even in Non-Remission Status

Possible Therapeutic Potential of Recombinant Human Soluble Thrombomoduline Alpha for the Treatment of SOS/VOD: A Retrospective Study in Toranomon Hospital

Umbilical Cord Blood Is the Most Significant Risk Factor for the Development of Bloodstream Infection after Allogeneic Hematopoietic Cell Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia Transformed from Ph-Negative Myeloproliferative Neoplasm: A Study from the Adult AML Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases

Clinical Comparison of Incidences, Risk Factors and Outocmes of Chronic Graft-Versus-Host Desease in Unrelated Cord Blood Transplantation and Unrelated Bone Marrow Transplantation

Early Central Nervous System Complications after Allogeneic Stem Transplantation: A Single-Center Analysis of 723 Patients Including 456 Cord Blood Recipients

Second Cord Blood Transplantation for Relapsed Myeloid Malignancies Following Allogeneic Transplantation – a Single Institute Analysis for 85 Recipients

A Novel Reduced-Toxicity Myeloablative Conditioningusing Full-Dose Busulfan and Melphalan For Cord Blood Transplantation Provides Durable Engraftment and Remission Without Increasing Non-Relapse Mortality In Advanced Myeloid Malignancies

Infliximab Versus Rabbit Anti-Thymocyte Globulin As a Salvage Treatment For Steroid-Refractory Acute Graft-Versus-Host Disease After Reduced-Intensity Cord Blood Transplantation In Adults

Membrane-Bound Human Stem Cell Factor Promotes Differentiation of Human Granulocytes and Mast Cells In Vivo,

Clostridium Difficile Infections After Allogenic Hematopoietic Stem Cell Transplantation: Comparison of Cord Blood to Other Grafts

Cell Cycle Entry Potentiates Elimination of Chemotherapy-Resistant Human AML Stem Cells.

Pre-Transplant Conditioning Using Intravenous Busulfan Is a Feasible and Effective Option in Reduced-Intensity Cord Blood Transplantation.

HHV6-Associated Limbic Encephalitis after Reduced-Intensity Umbilical Cord Blood Transplantation.

Voriconazole Is Safe and Effective as a Prophylactic Regimen of Invasive Fungal Infections for High Risk Patients after Reduced-Intensity Umbilical Cord Blood Transplantation

Comparison of Outcomes of Bone Marrow and Umbilical Cord Blood Transplants from Unrelated Donors in Adult Patients with Acute Myeloid Leukemia/Myelodysplastic Syndrome.

Comparative Single-Institute Analysis of Cord Blood Transplantation from Unrelated Donors with Unrelated Bone Marrow or Related Peripheral Blood Stem-Cell Transplants in Elderly Patients with Hematologic Diseases after Reduced Intensity-Conditioning Regimen.

Bloodstream Infection after Reduced-Intensity Umbilical Cord Blood Transplantation Versus Other Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only